NNPI Program
Transplant-Associated Herpesviruses
ResearchActive (Combined program with Gilead)
Key Facts
Indication
Transplant-Associated Herpesviruses
Phase
Research
Status
Active (Combined program with Gilead)
Company
About Assembly Biosciences
Assembly Biosciences is a focused antiviral specialist with a mission to develop innovative therapeutics for serious viral diseases. Its strategy is validated by a major partnership with Gilead Sciences, which licensed its lead herpesvirus programs, and a clinical pipeline featuring promising candidates for HSV-2, HDV, and HBV. The company applies a targeted platform approach to discover small molecules with novel mechanisms of action, aiming to address the limitations of current standards of care.
View full company profile